Cargando…
IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indic...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467658/ https://www.ncbi.nlm.nih.gov/pubmed/26089695 http://dx.doi.org/10.2147/CCID.S72301 |
_version_ | 1782376396967903232 |
---|---|
author | Yutskovskaya, Yana Gubanova, Elena Khrustaleva, Irina Atamanov, Vasiliy Saybel, Anastasiya Parsagashvili, Elena Dmitrieva, Irina Sanchez, Elena Lapatina, Natalia Korolkova, Tatiana Saromytskaya, Alena Goltsova, Elena Satardinova, Elmira |
author_facet | Yutskovskaya, Yana Gubanova, Elena Khrustaleva, Irina Atamanov, Vasiliy Saybel, Anastasiya Parsagashvili, Elena Dmitrieva, Irina Sanchez, Elena Lapatina, Natalia Korolkova, Tatiana Saromytskaya, Alena Goltsova, Elena Satardinova, Elmira |
author_sort | Yutskovskaya, Yana |
collection | PubMed |
description | BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indications. This article reports the outcomes of two expert consensus meetings, conducted to review and analyze efficacy and tolerability data for incobotulinumtoxinA in various facial aesthetic indications and to give expert consensus recommendations to ensure best clinical practice among Russian clinicians. METHODS: Thirteen dermatology and/or plastic surgery experts attended meetings held in Paris, France (November 2013), and Moscow, Russia (March 2014). The expert group reviewed and analyzed the existing evidence, consensus recommendations, and Russian experts’ extensive practical experience of incobotulinumtoxinA in aesthetics to reach consensus on optimal doses, potential dose adjustments, and injection sites of incobotulinumtoxinA for facial aesthetics. RESULTS: All experts developed guidance on the optimal doses for incobotulinumtoxinA treatment of different regions of the upper and lower face. The expert panel agreed that there are no differences in the efficacy and duration of the effect between the four BoNT/As that are commercially available for facial aesthetic indications in Russia and that, when administered correctly, all BoNT/As can achieve optimal results. Experts also agreed that nonresponse to BoNT/A can be caused by neutralizing antibodies. CONCLUSION: On the basis of the scientific and clinical evidence available for incobotulinumtoxinA, coupled with the extensive clinical experience of the consensus group, experts recommended the optimal doses of incobotulinumtoxinA effective for treatment of wrinkles of the upper and lower face to achieve the expected aesthetic outcome. These first Russian guidelines on the optimal use of incobotulinumtoxinA for augmentation of glabellar lines, periorbital wrinkles, forehead lines, bunny lines, perioral wrinkles, depressor anguli oris, mentalis, masseters and platysmal bands, and performing the Nefertiti lift, are presented here. |
format | Online Article Text |
id | pubmed-4467658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44676582015-06-18 IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations Yutskovskaya, Yana Gubanova, Elena Khrustaleva, Irina Atamanov, Vasiliy Saybel, Anastasiya Parsagashvili, Elena Dmitrieva, Irina Sanchez, Elena Lapatina, Natalia Korolkova, Tatiana Saromytskaya, Alena Goltsova, Elena Satardinova, Elmira Clin Cosmet Investig Dermatol Expert Opinion BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indications. This article reports the outcomes of two expert consensus meetings, conducted to review and analyze efficacy and tolerability data for incobotulinumtoxinA in various facial aesthetic indications and to give expert consensus recommendations to ensure best clinical practice among Russian clinicians. METHODS: Thirteen dermatology and/or plastic surgery experts attended meetings held in Paris, France (November 2013), and Moscow, Russia (March 2014). The expert group reviewed and analyzed the existing evidence, consensus recommendations, and Russian experts’ extensive practical experience of incobotulinumtoxinA in aesthetics to reach consensus on optimal doses, potential dose adjustments, and injection sites of incobotulinumtoxinA for facial aesthetics. RESULTS: All experts developed guidance on the optimal doses for incobotulinumtoxinA treatment of different regions of the upper and lower face. The expert panel agreed that there are no differences in the efficacy and duration of the effect between the four BoNT/As that are commercially available for facial aesthetic indications in Russia and that, when administered correctly, all BoNT/As can achieve optimal results. Experts also agreed that nonresponse to BoNT/A can be caused by neutralizing antibodies. CONCLUSION: On the basis of the scientific and clinical evidence available for incobotulinumtoxinA, coupled with the extensive clinical experience of the consensus group, experts recommended the optimal doses of incobotulinumtoxinA effective for treatment of wrinkles of the upper and lower face to achieve the expected aesthetic outcome. These first Russian guidelines on the optimal use of incobotulinumtoxinA for augmentation of glabellar lines, periorbital wrinkles, forehead lines, bunny lines, perioral wrinkles, depressor anguli oris, mentalis, masseters and platysmal bands, and performing the Nefertiti lift, are presented here. Dove Medical Press 2015-06-05 /pmc/articles/PMC4467658/ /pubmed/26089695 http://dx.doi.org/10.2147/CCID.S72301 Text en © 2015 Yutskovskaya et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Expert Opinion Yutskovskaya, Yana Gubanova, Elena Khrustaleva, Irina Atamanov, Vasiliy Saybel, Anastasiya Parsagashvili, Elena Dmitrieva, Irina Sanchez, Elena Lapatina, Natalia Korolkova, Tatiana Saromytskaya, Alena Goltsova, Elena Satardinova, Elmira IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title | IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title_full | IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title_fullStr | IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title_full_unstemmed | IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title_short | IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations |
title_sort | incobotulinumtoxina in aesthetics: russian multidisciplinary expert consensus recommendations |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467658/ https://www.ncbi.nlm.nih.gov/pubmed/26089695 http://dx.doi.org/10.2147/CCID.S72301 |
work_keys_str_mv | AT yutskovskayayana incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT gubanovaelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT khrustalevairina incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT atamanovvasiliy incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT saybelanastasiya incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT parsagashvilielena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT dmitrievairina incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT sanchezelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT lapatinanatalia incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT korolkovatatiana incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT saromytskayaalena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT goltsovaelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations AT satardinovaelmira incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations |